Xiamen Kingdomway Group Co

Kingdomway announced on September 29 that the company and its subsidiaries Inner Mongolia Kingdomway Co., Ltd. and Kingdomway Biotechnology Jiangsu Co., Ltd. recently received one invention patent certificate issued by the China National Intellectual Property Administration. The patent is titled "A Chondroitin Fermentation Production Control Method," with patent number ZL2026 10019817.6, and a patent term of twenty years. In the first half of 2026, Kingdomway achieved revenue of 1.773 billion yuan and net profit attributable to the parent company of 170 million yuan.

Xiamen Jindawei Group Co., Ltd. announced that the company and its subsidiaries, Inner Mongolia Jindawei Pharmaceutical Co., Ltd. and Jindawei Biotechnology (Jiangsu) Co., Ltd., recently received one invention patent certificate issued by the National Intellectual Property Administration. The patent is titled "A Separation and Purification Method for Pyrroloquinoline Quinone Disodium Salt," with patent number ZL202510024727.1, and the grant announcement date is July 17, 2026. The patent belongs to the field of compound purification technology and can effectively improve the purity of pyrroloquinoline quinone disodium salt. The company stated that the acquisition of this patent will not have a significant impact on production and operations, but it is conducive to technological innovation and enhances core competitiveness.

Jindawei and its subsidiaries recently obtained two Chinese invention patents and one U.S. invention patent. The Chinese patents include a carboxylesterase mutant, its preparation method, and a method for preparing S-3-cyclohexene-1-carboxylic acid using it, as well as a sweet protein mutant, its preparation method, and applications, with both granted on June 30, 2026. The U.S. patent covers a carbonyl reductase mutant, its preparation method and applications, and a method for preparing ethyl R-6-hydroxy-8-chlorooctanoate, granted on June 23, 2026. The company stated that these patents will not have a significant impact on near-term production and operations, but will benefit technological innovation and improve the intellectual property protection system.